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Several features common to a Western lifestyle, including obesity and low levels of physical activity, are known risk factors for gastrointestinal cancers 1 . There is substantial evidence suggesting that diet markedly affects the composition of the intestinal microbiota 2 . Moreover, there is now unequivocal evidence linking dysbiosis to cancer development 3 . However, the mechanisms by which high-fat diet (HFD)-mediated changes in the microbial community affect the severity of tumorigenesis in the gut remain to be determined. Here we demonstrate that an HFD promotes tumour progression in the small intestine of genetically susceptible, K-ras G12Dint , mice independently of obesity. HFD consumption, in conjunction with K-ras mutation, mediated a shift in the composition of the gut microbiota, and this shift was associated with a decrease in Paneth-cell-mediated antimicrobial host defence that compromised dendritic cell recruitment and MHC class II molecule presentation in the gut-associated lymphoid tissues. When butyrate was administered to HFD-fed K-ras G12Dint mice, dendritic cell recruitment in the gut-associated lymphoid tissues was normalized, and tumour progression was attenuated. Importantly, deficiency in MYD88, a signalling adaptor for pattern recognition receptors and Toll-like receptors, blocked tumour progression. The transfer of faecal samples from HFD-fed mice with intestinal tumours to healthy adult K-ras G12Dint mice was sufficient to transmit disease in the absence of an HFD. Furthermore, treatment with antibiotics completely blocked HFD-induced tumour progression, suggesting that distinct shifts in the microbiota have a pivotal role in aggravating disease. Collectively, these data underscore the importance of the reciprocal interaction between host and environmental factors in selecting a microbiota that favours carcinogenesis, and they suggest that tumorigenesis is transmissible among genetically predisposed individuals.
Undoubtedly, a variety of factors contribute to the aetiology of intestinal cancer. There are compelling arguments to include an HFD and the composition of the gut microbiota as key risk factors 4 . Given the rapid increase in the incidence of diet-induced obesity worldwide 5 and the recent evidence that the microbiota in obese individuals is more efficient at harvesting nutrients 6, 7 , it is crucial to understand the role of the gut microbiota in the pathogenesis of cancer.
We set out to elucidate whether alterations in the gut microbial community are the link between an HFD and pathogenesis of intestinal cancer. To that end, we used a well-characterized serrated hyperplasia model with oncogenic K-ras expression in the intestinal epithelium (Kras G12Dint mice) 8 and exposed these mice to an HFD regimen for 22 weeks (Fig. 1a) . Whereas 33% of age-matched K-ras G12Dint mice on a normal diet developed only murine serrated hyperplasia along the intestine, HFD consumption led to further tumour progression in 60% of K-ras G12Dint mice (Fig. 1b) . These mice developed tumours in the duodenum that ranged from murine serrated adenoma, with low-grade dysplasia (mSA-LGD) and high-grade dysplasia (mSA-HGD), to invasive carcinoma, closely recapitulating the carcinogenic sequence in humans (Fig. 1c) . These cells metastasized to the liver, pancreas and spleen when mice were maintained on an HFD for 40 weeks (Extended Data Fig. 1a ). Serrated tumours revealed increased proliferation at the tips of the villi; such proliferation was otherwise restricted to the crypt region (Extended Data Fig. 1b) . Importantly, diet-induced obesity was compromised in K-ras G12Dint mice during disease progression (Extended Data Fig. 1c ). In accordance with the increased insulin sensitivity observed in these animals, lipid accumulation in the liver was lower than in littermate controls that were fed an HFD for 22 weeks (Extended Data Fig. 1d, e) . Taken together, these data suggest that diet-mediated effects on the host were responsible for promoting serrated tumour progression in the small intestine.
An HFD induces a low-grade inflammatory state 9 , and inflammation is a hallmark of cancer 10 . Unexpectedly, tumour-necrosis factor-a (TNFa), as well as the macrophage cell surface marker F4/80, were downregulated in the duodenum of K-ras G12Dint mice (Extended Data Fig. 1f ). Moreover, duodenal samples from K-ras G12Dint animals exhibited a significant reduction in the expression of genes involved in the recognition of, and immune response to, antigens, suggesting that an oncogene-driven downmodulation of host immunity had occurred ( Fig. 1d and Extended Data Fig. 2a ). This downregulation was associated with decreased Paneth-cell-mediated antimicrobial defence and altered expression of differentiation markers in the small intestine (Extended Data  Fig. 2b, c) . On exposure to bacteria or bacterial antigens, Paneth cells secrete defensins (cryptdins), which have antibacterial function during immune responses and thereby shape the composition of the microbiota 11 . This activity was significantly decreased in K-ras G12Dint mice regardless of the tumour incidence (Extended Data Fig. 2a, c) . The intestinal epithelium is covered by a mucus layer, which is largely composed of mucins and provides a physical barrier, thereby limiting damage to the epithelium and enhancing gut homeostasis by delivering tolerogenic signals 12 . Indeed, the expression of the mucin MUC2 was significantly decreased after HFD intake (Extended Data Fig. 2c ). In agreement with the duodenal gene expression data, MHC class II expression in CD11c 1 and CD11b 1 cell populations in the lamina propria (Fig. 1e) , as well as in the Peyer's patches (Extended Data Fig. 2d ), was significantly reduced in K-ras G12Dint mice regardless of diet. Taken together, these data suggest that diminished cryptdin expression by Paneth cells, owing to oncogene activation in combination with altered mucin profiles caused by an HFD, could render K-ras G12Dint mice susceptible to dampened immunity.
An HFD can lead to marked changes in the secretory, absorptive and immune function of the gut by regulating microbial communities 13 . To define whether HFD-induced alterations in the microbiota were associated with the increased tumour incidence, amplicons generated from small intestinal and colonic faecal DNA were subjected to 16S ribosomal RNA gene sequencing. The HFD altered the community diversity in Figure 1 | An HFD accelerates cancer progression. a, The experimental scheme shows when and how long the special diet (HFD) was administered before final analysis. ND, normal diet. b, Histological scores show tumour incidence in the small intestine with the HFD regimen. Each point represents one animal, and lines indicate the mean (ND, LSL-K-ras G12D/1 controls n 5 5, K-ras G12Dint mice, n 5 6; HFD, LSL-K-ras G12D/1 controls n 5 13, K-ras G12Dint mice n 5 16). The scores were assessed using a two-sided Fisher test, and adjustments on pairwise t-tests were made using the single-step method. Linear discriminant analysis (LDA) effect size (LEfSe) results show bacteria that were significantly different in abundance between K-ras G12Dint mice on a ND and an HFD regimen, and they indicate the effect size of each differentially abundant bacterial taxon in the small intestine (ND, n 5 3; HFD, n 5 8) (a) and the colon (ND, n 5 3; HFD, n 5 7) (b).
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the intestine compared with the normal diet. The abundance of Helicobacteraceae, Lactobacillaceae, Enterobacteriaceae, Clostridiaceae and Peptostreptococcaceae was significantly higher in the small intestine of K-ras G12Dint mice fed an HFD than in those fed a normal diet, whereas the abundance of Bifidobacteriaceae, Porphyromonadaceae and Alcaligenaceae was significantly lower (Fig. 2a) . Moreover, although no tumours were detected in the colon, the abundance of Enterobacteriaceae, Desulfovibrionaceae, Porphyromonadaceae, Rikenellaceae, Ruminococcaceae, Lachnospiraceae, Coriobacteriaceae and Deferribacteraceae was significantly higher in the colonic tissue of K-ras G12Dint mice fed an HFD than in those fed a normal diet, whereas the abundance of Bifidobacteriaceae, Peptostreptococcaceae, Roseburia and Butyricicoccus was significantly lower (Fig. 2b) . Overall, the HFD initiated a major structural change in the gut microbiota in tumour-bearing K-ras G12Dint mice ( Fig. 2 and Extended Data Fig. 3a-c) .
Bacteria are sensed through pattern recognition receptors, Toll-like receptors and the downstream adaptor protein MYD88 (ref. 14). Interestingly, systemic ablation of Myd88 conferred complete protection against tumour progression, suggesting a causal role for intestinal microbiota in the tumorigenic process (Extended Data Fig. 4a ). To distinguish which Myd88-deficient cell type conferred protection against tumorigenesis, K-ras G12Dint mice were either crossed to Myd88 fl/fl animals or transplanted with Myd88-deficient bone marrow to restrict Myd88 deletion to intestinal epithelial cells (IECs) or haematopoietic cells, respectively.
K-ras
G12Dint mice continued to develop invasive cancer when Myd88 deletion was restricted to the IECs (Extended Data Fig. 4a ). Although the adoptive transfer of Myd88-deficient bone marrow slightly reduced tumour incidence, it did not prevent tumour progression, as the number of invasive cancers was comparable to that in mice that had received wild-type bone marrow cells (Extended Data Fig. 4a ).
Defective innate immunity has been suggested to shape a distinct intestinal microbiota in mice [15] [16] [17] . To test whether the discrepancy in tumour incidence between germline and tissue-specific Myd88 deficiency was due to a change in the gut microbiota, we surveyed microbial community diversity. Systemic deletion of Myd88 led to an increase in Peptostreptococcaceae, Deferribacteraceae, and butyrate-producing Ruminococcaceae (Extended Data Fig. 4b ). Furthermore, Enterococcaceae, the abundance of which was consistently increased after tissue-specific Myd88 deletion, was not detectable when Myd88 was deleted from the germ line (Extended Data Fig. 5a-c) . Remarkably, oncogene-and dietuncoupled antigen presentation in dendritic cells of the lamina propria was significantly attenuated after systemic Myd88 deletion (Extended Data Fig. 4c ). A possible explanation for the differential susceptibility to cancer is that in systemic deletion, the deletion of Myd88 in IECs and haematopoietic cells has an additive protective effect. Alternatively, systemic Myd88 deficiency might have prevented tumour progression by mechanisms that are not only associated with community changes or mucosal immunity but rather by altering IEC differentiation during embryogenesis.
The ingestion of dietary fibre promotes short-chain fatty acid (SCFA) formation and has beneficial effects on health by selectively affecting a restricted number of bacterial genera (Bifidobacterium and Lactobacillus) controls, n 5 5; K-ras G12Dint mice, n 5 5), after galacto-oligosaccharide (GOS) supplementation (LSL-K-ras G12D/1 controls, n 5 10; K-ras G12Dint mice, n 5 12) and after butyrate supplementation (LSL-K-ras G12D/1 controls, n 5 6; K-ras G12Dint mice, n 5 7). Each point represents one animal, and the lines indicate the mean. The scores were assessed using a one-way analysis of variance (ANOVA), and adjustments on pairwise t-tests were made using the single-step method. *, P # 0.05; NS, not significant. b, LEfSe results show the bacteria that were significantly different in abundance between K-ras G12Dint mice on an HFD that were treated (n 5 5) or not treated (n 5 8) with butyrate, and they indicate the effect size of each differentially abundant bacterial taxon in the small intestine. c, The gene expression profiles of selected top candidate genes involved in antigen recognition, the immune response and immune cell recruitment in duodenal samples from LSL-K-ras G12D/1 controls and littermate K-ras G12Dint animals (n 5 3 per group) that were on the ND or HFD regimen and were treated or not treated with butyrate. P values were obtained from the moderated t-statistic and corrected for multiple testing with the Benjamini-Hochberg method. d, Flow cytometric analysis of LP cells from LSL-K-ras G12D/1 control and K-ras G12Dint littermate animals on an HFD treated with butyrate (LSL-K-ras G12D/1 controls, n 5 4; K-ras G12Dint mice, n 5 7) or not treated with butyrate (LSL-K-ras G12D/1 controls, n 5 2; K-ras G12Dint mice n 5 2). P values were determined by one-way ANOVA and adjusted for the number of comparisons by using the Bonferroni method. Error bars indicate s.e.m. *, P # 0.05.
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in the gut 18 . HFD-induced tumour progression was correlated with a significant reduction in acetate, propionate and butyrate concentrations in faecal samples (Extended Data Fig. 6a, b) . To ascertain whether diet-induced tumorigenesis could be halted through further changes in the microbiota, prebiotics were administered to mice. Interestingly, arabinogalactan supplementation did not provide any protective effect (Fig. 3a) . However, different prebiotics are available, with the key differentiating factor being the length of the chemical chain, which determines where in the gastrointestinal tract the prebiotic exerts its effect 19 . Supplementation of the diet with galacto-oligosaccharide (GOS) did not affect tumour incidence (Fig. 3a) but slightly increased the number of tumours per mouse. CD11c 1 dendritic cell numbers and MHC class II presentation on CD11c 1 dendritic cells in the lamina propria and mesenteric lymph nodes (MLNs) (Extended Data Fig. 6c) , as well as expression of the genes involved in the immune response (Extended Data Fig. 7a ), were equally reduced in HFD-fed K-ras G12Dint mice that had been treated with GOS and those that had not (compare with Extended Data Fig. 2) . The lack of a protective effect could be due to the prebiotics having little or no effect on SCFA production throughout the gut (Extended Data Fig. 7b ). In addition, SCFA levels were significantly lower in the small intestine than in colonic and faecal samples (Extended Data Fig. 6b ).
Therefore, we next sought to determine whether diet-induced tumour progression could be prevented when mice were orally treated with butyrate. SCFAs, the end products of colonic bacterial fermentation, have several beneficial effects on the host. They serve as an energy source, modulate intestinal motility, are a defence barrier and have been suggested to have immunoregulatory functions 20, 21 . Although butyrate supplementation led to only a minor increase in the faecal butyrate concentration (Extended Data Fig. 8a) , it markedly reduced the tumour incidence (Fig. 3a) . This decrease was associated with a significant increase in the abundance of Bifidobacteriaceae and Porphyromonadaceae and a sharp decrease in Helicobacteraceae in the small intestine (Fig. 3b) . Interestingly, branching, serration and proliferation were partially blocked in K-ras G12Dint mice on treatment with butyrate (Extended Data Fig. 8b ). The HFD-induced decrease in the expression of Muc2 (Extended Data Fig. 8c ) and genes involved in antigen recognition and the immune response (Fig. 3c ) was partially restored towards the level of the normal diet group. Moreover, compromised dendritic cell recruitment was nearly normalized (Fig. 3d) . Although most studies have focused on colonic bacteria, the small intestine has a crucial role in carbohydrate and fat uptake 22 . However, the concentration of SCFAs in the small intestine remained lower than that in colonic or faecal samples (Extended Data  Fig. 6b) . Butyrate seemed to be a potent SCFA, with systemic effects on K-ras G12Dint animals, and antibiotic treatment abolishes tumorigenesis. a, The experimental scheme indicates the time of stool transfer from HFD-fed donors that had been on the diet regimen for 24 weeks to healthy 7-week-old K-ras G12Dint recipients on a ND after 1 week of antibiotic (Abx) treatment. The histological score of the small intestine suggested that a disease-associated microbiota had been delivered, as well as increased tumour incidence in the recipient K-ras G12Dint mice (LSL-K-ras G12D/1 controls, n 5 6; K-ras G12Dint mice, n 5 11). Each point represents one animal, and the lines indicate means. The scores between K-ras G12Dint mice treated or not treated with stool samples were assessed using a two-sided, two-sample Welch's t-test. *, P # 0.05. b, LEfSe results show bacteria that were significantly different in abundance between ND-fed K-ras G12Dint mice that underwent stool transfer (n 5 6) or did not undergo stool transfer (n 5 3). c, Flow cytometric analysis of LP cells from mice after stool transfer (ND, LSL-K-ras G12D/1 controls n 5 2, K-ras G12Dint mice n 5 2; ND 1 stool transfer, LSL-K-ras G12D/1 controls n 5 7, K-ras G12Dint mice n 5 10). P values were determined by one-way ANOVA and adjusted for the number of comparisons by using the Bonferroni method. Error bars indicate s.e.m. *, P # 0.05; **, P # 0.01; ***, P # 0.001; ### , P # 0.001 compared with littermate controls. d, The experimental scheme indicating the application of the antibiotic regimen during the course of the HFD and the time point for data analysis. The histological scores of the small intestine samples showed complete protection against tumour formation in the HFD-fed K-ras G12Dint mice treated with antibiotics (HFD 1 Abx, LSL-K-ras G12D/1 controls, n 5 7; K-ras G12Dint mice, n 5 7). Each point represents one animal, and the lines indicate means. The scores were assessed using a two-sided Fisher test, and adjustments on pairwise t-tests were made using the single-step method. **, P # 0.01. e, Flow cytometric analysis of LP cells showing the recruitment of, and surface antigen presentation on, CD11c
1 dendritic cells in disease-free K-ras G12Dint mice after treatment with antibiotics (HFD 1 Abx, LSL-Kras G12D/1 controls n 5 5, K-ras G12Dint mice n 5 7; HFD, LSL-K-ras G12D/1 controls n 5 2, K-ras G12Dint mice n 5 2). P values were determined by one-way ANOVA and adjusted for the number of comparisons by using the Bonferroni method. Error bars indicate s.e.m. The differences are not significant. Data Fig. 8d) , although histone H3 and H4 acetylation remained unaffected (Extended Data Fig. 8e ). These results indicate that butyrate exerts its protective effect on tumorigenesis at least in part through changes in bacterial composition and through regulating K-Ras signalling.
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To confirm the causal relationship between diet-induced dysbiosis and intestinal cancer, mice on the normal diet were treated for 1 week with an antibiotic mixture and then colonized with fresh faecal samples from HFD-fed K-ras G12Dint donors. Remarkably, disease was transmitted to otherwise healthy K-ras G12Dint mice on a normal diet but not to LSL-K-ras G12D/1 controls (Fig. 4a and Extended Data Fig. 9a ). Comparison of the microbial community composition between K-ras G12Dint mice that did and did not undergo stool transfer showed a higher abundance of Lactobacillaceae, Helicobacteraceae and Clostridiales in stool recipients, reflecting the transfer of the HFD-shaped microbiota to the normal diet phenotype (Fig. 4b and Extended Data Fig. 9b ). MUC2 expression was significantly lower in mice that received the stool than in those that did not, reminiscent of the HFD group (Extended Data Fig. 10a) . The recruitment of dendritic cells and MHC class II presentation by dendritic cells in the lamina propria and Peyer's patches were also compromised in mice that received the stool (Fig. 4c and Extended Data Fig. 9c ), and glucose clearance during a glucose tolerance test was similar to that of the normal diet group (compare Extended Data Fig. 9d with Fig. 1d ). These findings provide evidence that a diet-shaped microbiota synergizes with oncogenic K-ras during tumorigenesis in the intestine, independently of obesity.
To further support the evidence that a distinct shift in bacterial community has a causative role in tumour progression, the mice were treated with antibiotics. In support of the stool transfer experiments and the existence of a disease-associated microbiota, antibiotic supplementation abolished tumour formation in K-ras G12Dint mice (Fig. 4d) . The HFD-mediated downregulation of genes involved in the immune response, the mucin profile and the differentiation markers in the duodenum were less pronounced after antibiotic treatment (Extended Data  Fig. 7a ). MHC class II presentation by dendritic cells was still compromised in the lamina propria after antibiotic treatment (Fig. 4e) but not in the MLNs (Extended Data Fig. 10b ). Taken together, these results suggest a critical role for diet-shaped dysbiotic bacteria in aggravating oncogene-driven intestinal carcinogenesis (Extended Data Fig. 10c) .
The perturbation of immunoregulatory functions by a dysbiotic microbiota is becoming increasingly recognized as a hallmark of immunemediated diseases 3 . However, diet-associated cancer development may be based on marked shifts in bacterial communities rather than on the development of obesity and metabolic disorder. Thus, personalized dietary interventions might allow an individual's microbiota to be modulated to promote health, especially in those who are at a high risk because of genetic susceptibility and a high fat intake.
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K-ras
G12Dint mice on a C57BL/6J;129 background have been described previously 8 . The mice were fed either with a total pathogen-free diet (Altromin, catalogue no. 1314; percentage of total calories, 27% protein, 60% carbohydrate and 13% fat) (Supplementary Table 1 ) or a c-irradiated HFD (Research Diets, catalogue no. D12492; percentage of total calories, 20% protein, 20% carbohydrate and 60% fat) (Supplementary Table 2 ). Sections from the small intestine and colon were evaluated and scored by pathologists in a blinded manner. For immunohistochemistry, paraffin-embedded sections were stained according to standard procedures using a monoclonal rat anti-5-bromodeoxyuridine (BrdU) antibody (1:200; AbD Serotec, catalogue no. MCA 2060) and counterstained with haematoxylin. BrdU (100 mg per kg body weight; Sigma, catalogue no. B9285) was intraperitoneally injected 2 h before the mice were killed.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. work was supported by grants from the Deutsche Krebshilfe (107977) Author Information Microarray data were generated in accordance with the MIAME guidelines and have been deposited in the Gene Expression Omnibus (GEO) database under accession number GSE56257. Sequence data have been deposited in the NCBI Sequence Read Archive (SRA) database under BioProject PRJNA242565 (SRA project accession number, SRP040736; sample accession numbers, SRS584259-SRS584323, SRS584325). Reprints and permissions information is available at www.nature.com/reprints. The authors declare no competing financial interests. Readers are welcome to comment on the online version of the paper.
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Mice. Littermate mice were co-housed randomly regardless of their genotype during the various diet and additional nutritional supplementation regimens. However, during stool transfer experiments, the mice were separated and co-housed according to their genotypes to avoid cross contamination. During treatment with antibiotics, the drinking water was supplemented with a mixture of 0.2 g l 21 ampicillin, 0.1 g l 21 vancomycin, 0.2 g l 21 neomycin and 0.2 g l 21 metronidazole. During transfer experiments, following antibiotic treatment for 1 week, 7-week-old mice were colonized with fresh stool pellets (9 3 10 6 bacteria) from mice that had been fed the HFD for 24 weeks. GOS (Bi2muno) (5.5 g) was provided in 150 ml drinking water, which was refreshed every 2 days. Sodium butyrate (Aldrich, catalogue no. 303410) (50 mg per g body weight in 100 ml water) and arabinogalactan (Fluka, catalogue no. A-09788) (0.01 per g body weight in 100 ml water) were provided orally three times a week. K-ras G12Dint mice were further crossed to Myd88 fl/fl and Myd88
-/-mice (Jackson Laboratory). During adoptive transfer experiments, 6-week-old Kras G12Dint mice were irradiated (9 Gy), and 2 3 10 6 bone marrow cells from Myd88
-/-or wild-type mice were transferred by tail vein injection to recipients. The procedures were approved by the Regierung von Oberbayern. Human samples. Human samples were analysed after irreversible anonymization of the patients' personal data. Histological sections were microscopically evaluated by pathologists after haematoxylin and eosin staining. All procedures were performed according to the recommendation of the ethics committee of Ludwig Maximilians University.
Glucose tolerance test (GTT). Following 9 h of fasting, the basal glucose level was detected using a glucometer (Bayer, catalogue no. 3822850). Mice were injected with 1.5 g glucose per kg body weight (40% glucose solution, Eifelfango), and blood glucose levels were recorded for up to 2 h. Plasma samples were collected simultaneously, and insulin secretion was measured with the Ultra Sensitive Rat Insulin ELISA Kit (Crystal Chem, catalogue no. 90060) using a mouse standard (Crystal Chem, catalogue no. 90070). The tests were assessed in a blinded manner. RNA analysis. Total RNA was extracted from the small and large intestine using the RNeasy Mini Kit (QIAGEN). cDNA was synthesized using SuperScript II Reverse Transcriptase (Invitrogen). Real-time PCR analysis using Power SYBR Green PCR Master Mix (Applied Biosystems) was carried out on a StepOnePlus RealTime PCR System (Applied Biosystems). The primer sequences used are as follows: Microarray analysis using the GeneChip Mouse Gene 1.0 ST array. RNA isolation from three biological replicates of duodenal samples was carried out using the TRIzol (Invitrogen) method according to the manufacturer's instructions. The samples were treated with DNase I (Sigma-Aldrich). RNA quality was checked by microfluidic electrophoresis using the 2100 Bioanalyzer (Agilent Technologies), and only samples with comparable RNA integrity numbers were processed for microarray analysis. cDNA was synthesized using 0.3 mg of total RNA. The synthesis of the doublestranded cDNA was performed using WT Target Labeling and Control Reagents (Affymetrix), and the clean-up was carried out using the GeneChip Sample Cleanup module (Affymetrix).
In vitro transcription was conducted using the WT Target Labeling Kit. The total amount of the reaction product was purified using the GeneChip Sample Cleanup Module and quantified with the ND-1000 (NanoDrop, Thermo). cDNA synthesis (single strand, ss) was carried out with the WT Target Labeling Kit, and total ssDNA (5.5 mg) was enzymatically cleaved into 35-200 base-pair fragments. The degree of fragmentation and the length distribution of the ssDNA were analysed by capillary electrophoresis using the 2100 Bioanalyzer. Following fragmentation, a terminal labelling reaction (with biotin) was conducted using the WT Labeling Kit.
Biotinylated fragmented ssDNA was then hybridized onto the GeneChip Mouse Gene 1.0 ST Array (Affymetrix) according to the manufacturer's instructions. The hybridization was carried out at 45 uC in the GeneChip Hybridization Oven 640 (Affymetrix) for 16 h. Washing and staining of the arrays on the GeneChip Fluidics Station 450 (Affymetrix) were performed according to the manufacturer's recommendations. Amplification of the antibody signal and washing and staining protocols were also according to the manufacturer's instructions and were used to stain the arrays with streptavidin R-phycoerythrin (SAPE, Invitrogen). The arrays were incubated twice with SAPE solution, together with a biotinylated anti-streptavidin antibody (Vector Labs) staining step, to amplify staining. Finally, the arrays were scanned using the GeneChip Scanner 3000 7G (Affymetrix). Microarray data processing and statistical analysis. AGCC Software (version 2.0, Affymetrix) was used for the extraction of intensity data, which were analysed using the affy 23 and Limma 24 packages of Bioconductor 25 . The analysis was carried out exactly as previously described 26 . The data analysis consisted of between-array normalization, probe summary, global clustering and principal components analysis (PCA) analysis, fitting of the data to a linear model and detection of differential gene expression. To ensure that the intensities had similar distributions across arrays, quantile normalization was applied to the log 2 -transformed intensity values as a method for between-array normalization 27 . Similarly to the summary of probes, a median polish procedure was chosen.
Significant changes in the expression of genes between the groups were analysed by empirical Bayes statistics, by moderating the standard errors of the estimated values 28 . P values obtained from the moderated t-statistic were corrected for multiple testing with the Benjamini-Hochberg method 29 . P-value adjustments guarantee a smaller number of false positive findings by controlling the false discovery rate (fdr). For each gene, the null hypothesis suggesting that there is no differential expression between degradation levels was rejected when the fdr was lower than 0.05. Samples were assessed in a blinded manner. Cell isolation from lamina propria. Intestinal tissue was cut into small pieces, shaken vigorously in 25 ml RPMI and washed three times with PBS. Tissue pieces were then incubated in 50 ml PBS containing 0.015 g dithiothreitol (DTT) and 500 ml 0.5 M EDTA with constant shaking for 20 min at 37 uC. The pieces were then collected and transferred to 10 ml RPMI containing 50 ml DNase I grade II (100 mg ml
21
) and 50 ml collagenase D (100 mg ml
) and then incubated for 25 min in a rotating incubator at 37 uC. Cells were passed through a cell strainer and centrifuged at 194g for 5 min, and the resultant pellet was resuspended in fluorescence-activated cell sorting (FACS) buffer (2% FCS in PBS). Cell isolation from the Peyer's patches. The Peyer's patches were excised from the intestine. They were incubated for 20 min in a mixture of 3 ml RPMI, 15 ml collagenase D (100 mg ml
) and 15 ml DNase I grade II (20 mg ml 21 ) at 37 uC. The solution was then passed through a cell strainer and incubated for 10 min at 37 uC. The reaction was stopped by the addition of 10 ml 0.5 M EDTA, and the volume was adjusted to 10 ml with RPMI. After centrifugation at 249g for 5 min, the cells were resuspended in FACS buffer. Cell isolation from the MLNs. The MLNs were collected in 5 ml 2% FCS in PBS, sheared on glass slides and passed through a 100 mm filter and then a 70 mm filter. Following centrifugation at 194g for 5 min at 4 uC, the erythrocytes were lysed with 1 ml of Red Blood Cell Lysing Buffer (Sigma) for 5 min at 20 uC. The pellets were then washed in 2% FCS in PBS, centrifuged at 194g for 5 min and resuspended in FACS buffer. FACS. After cell isolation from the lamina propria, Peyer's patches and MLNs, approximately 1 3 10 6 cells were stained with 0.5 mg ml 21 ethidium monoazide (EMA) (Sigma, catalogue no. E2028) to stain dead cells for 15 min under a light source. Cells were washed and incubated with mouse BD Fc Block (BD Pharmingen, clone 2.4G2, catalogue no. 553141) for 10 min on ice and then washed and centrifuged at 775g for 5 min. Fluorescently labelled antibodies (fluorescein isothiocyanate (FITC) rat antimouse CD11b antibody, BD Pharmingen, clone M1/70, catalogue no.557396; antimouse phycoerythrin (PE)-cyanine7 CD11c, eBioscience, clone N418, catalogue no. 25-0114-82; and allophycocyanin (APC) anti-mouse MHC class II (I-A/I-E), eBioscience, clone M5/114.15.2, catalogue no. 17-5321-81) (1:200) were added and incubated for 20 min on ice. After washing, cells were fixed by incubating in fixation buffer (eBioscience) for 30 min on ice. Following a further washing step, cells were suspended in FACS buffer, filtered using 50 mm filcons (Günter Keul) and sorted using the Gallios Flow Cytometer (Beckman Coulter). Data analyses were carried out using FlowJo software (version 8.8.6).
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Sample preparation and pyrosequencing. Stool samples were freshly collected and immediately frozen in liquid nitrogen. Genomic DNA was isolated from 200 mg frozen faecal samples using a QIAamp DNA Stool Mini Kit (QIAGEN). PCR amplification of the V1-V3 region of bacterial 16S ribosomal DNA was carried out using primers (338F, 59-ACTCCTACGGGAGGCAGCAG-39, 806R, 59-GGAC TACCAGGGTATCTAAT-39) incorporating FLX Titanium adaptors (Roche) and a sample barcode sequence. The PCR was made based on the 'Amplicon Library Preparation Method' (Roche) using a FastStart High Fidelity PCR System (Roche), 10 mM PCR Nucleotide Mix (Roche) and 10 ng stool DNA per reaction in a 25 ml reaction volume. After purification of the product on a 1.2% agarose gel, equal concentrations of amplicons were pooled from each sample. Emulsion PCR and GS FLX amplicon sequencing were carried out according to the Roche Titanium series chemistry.
Pyrosequenced amplicon libraries were screened for quality characteristics, chimaeric sequences, and PCR/pyrosequencing-induced duplication artefacts using AmpliconNoise and Perseus software (version 1.28) as previously described 30 . Cleaned data sets were processed using the QIIME amplicon analysis pipeline (version 1.7.0) 31 . Briefly, sequences were clustered into distance-based (97% similarity) operational taxonomic units (OTUs) using mothur software (version 1.30.2) 32 . Representatives of each OTU were aligned to the Greengenes core set alignment 33 using PyNAST software (version 1.1) 34 . Taxonomic assignments for each OTU were made using the Ribosomal Database Project (RDP) Classifier (version 2.2) 35 .
LEfSe results for microbiomes. LEfSe is an algorithm for applying 16S rRNA gene data sets to detect bacterial organisms and functional characteristics that are differentially abundant between two or more microbial environments 36 . It emphasizes statistical significance, biological consistency and effect relevance, allowing the identification of differentially abundant features that are also consistent with biologically meaningful categories (subclasses). LEfSe first robustly identifies features that are significantly different among biological classes. It then carries out additional tests to assess whether these differences are consistent with respect to expected biological behaviour. The non-parametric factorial Kruskal-Wallis (KW) rank-sum test is used to detect features with significant differential abundance with respect to the class of interest; biological consistency is subsequently investigated using a set of pairwise tests among subclasses using the (unpaired) Wilcoxon rank-sum test. As a last step, LEfSe uses linear discriminant analysis (LDA) to estimate the effect size of each differentially abundant feature. Samples were assessed in a blinded manner. SCFA measurement. Stool samples were freshly collected and immediately frozen in liquid nitrogen. A 1:5 dilution of the samples in double distilled water was centrifuged, and the supernatant was mixed with 12 mM isobutyric acid, 1 M NaOH and 0.36 M HClO 4 . After lyophilization for 16 h, the remaining powder was diluted with acetone and 5 M formic acid and centrifuged, and the supernatant was used for the measurement with an HP 5890 Series II gas chromatograph (Hewlett Packard). Samples were assessed in a blinded manner. Histone acetylation. Histones were extracted using an EpiQuik Total Histone Extraction Kit (Epigentek, catalogue no. OP-0006). H3 or H4 acetylation was determined using an EpiQuik Global Histone H3 (or H4) Acetylation Assay Kit (Epigentek, catalogue no. P-4008 and P-4009), according to the manufacturer's instructions. Statistical analysis. Outcomes on sufficiently metric scales (cell percentage, messenger RNA levels, SCFA levels, percentage histone acetylation) were assessed with linear models (one-way ANOVA), modelling the mean value of each group, which were defined through mutation, diet and diet supplementation. Relevant comparisons of mean values between groups were made with two-sided pairwise t-tests; the null hypotheses stated that there was no difference in the means. P values were adjusted for the number of comparisons by using the Bonferroni method.
Outcomes on a discrete/ordinal scale (histological scores) were either assessed using Fisher's exact test, Welch's t-test or one-way ANOVA models, as above.
Fisher's test was chosen when one of the groups comprised only values on a single outcome level, because in such a case the assumption of equal variances is hardly violated. A two-sided Fisher's test was applied to a two-by-two contingency table classifying the histological scores as either no pathology or any pathology. The ANOVA method was chosen when both groups had observations on at least two levels of the histological score and mimicked the Cochran-Mantel-Haenszel tests for linear trends in ordinal outcomes. Adjustments on pairwise t-tests were made using the single-step method 37 . Both types of adjustments control the family-wise error rate of making one or more false discoveries.
Outcomes measured over several time points (the GTT, insulin values and the weight curve) were assessed for differences between groups (LSL-K-ras G12D/1 control mice and K-ras G12Dint mice) with linear models. The models estimated the mean values of each group-time combination, and t-tests were carried out for every pair of mean values at a specific time point. P values were adjusted for multiple testing within each time series: that is, for 5 to 6 tests for glucose and insulin, and for 12 tests for the weight measurements. Adjustment was carried out with the singlestep method as mentioned above, which is implemented in the glht (general linear hypothesis) function in the R package multcomp.
The number of mice per group used in an experiment is annotated in the corresponding figure legend as n. Although no prior sample size estimation was performed, we have used as many mice per group as possible. No gender differences were observed. The significance of tests is reported as NS (not significant), * (P # 0.05), ** (P # 0.01) and *** (P # 0.001). Statistical tests were carried out using Prism4 (GraphPad Software) and R (R Core Team, 2013).
